Literature DB >> 215485

Clinical significance of mitochondrial glutamic-oxaloacetic transaminase in serum of patients with liver disease.

S Okuyama, Y Kato, A Funayama, A Kusakabe, T Hara, T Yamawaki, S Kurokawa, T Inagaki, S Ito, N Sakamoto.   

Abstract

Serum mitochondrial glutamic-oxaloacetic transaminase activity was determined in 83 patients with various liver diseases and 10 healthy adults. 1) The average of mitochondrial glutamic-oxaloacetic transaminase value was 1.2 mU in healthy adults, 8.3 mU in patients with acute hepatitis, 13.7 mU in patients with post-transfusion hepatitis, 5.0 mU in patients with persistent hepatitis, 4.5 mU in patients with chronic inactive hepatitis, 9.6 mU in patients with chronic active hepatitis, 5.6 mU in liver cirrhosis, and 295 mU in a patient with fulminant hepatitis. 2) While one patient with acute hepatitis showed the highest value in the group of 29 mU, one patient with fulminant hepatitis showed an extremely high value of 295 mU, revealing an obvious difference between them. 3) One patient with fresh myocardial infarction also showed an extremely high value of 110 mU.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 215485     DOI: 10.1007/bf02776011

Source DB:  PubMed          Journal:  Gastroenterol Jpn        ISSN: 0435-1339


  7 in total

Review 1.  COMPARATIVE STUDIES ON GLUTAMIC-OXALACETIC TRANSAMINASES FROM THE MITOCHONDRIAL AND SOLUBLE FRACTIONS OF MAMMALIAN TISSUES.

Authors:  H WADA; Y MORINO
Journal:  Vitam Horm       Date:  1964       Impact factor: 3.421

2.  The intracellular distribution, latency and electrophoretic mobility of L-glutamate-oxaloacetate transaminase from rat liver.

Authors:  J W BOYD
Journal:  Biochem J       Date:  1961-11       Impact factor: 3.857

3.  Separation of 2 glutamic-oxalacetic transaminases by paper electrophoresis.

Authors:  G A FLEISHER; C S POTTER; K G WAKIM
Journal:  Proc Soc Exp Biol Med       Date:  1960-01

4.  Differences between the transaminases in mitochondria and soluble fraction. II. Glutamic-oxaloacetic transaminase.

Authors:  N KATUNUMA; T MATSUZAWA; A HUZINO
Journal:  J Vitaminol (Kyoto)       Date:  1962-03-10

5.  A note on the spectrometric assay of glutamic-oxalacetic transaminase in human blood serum.

Authors:  A KARMEN
Journal:  J Clin Invest       Date:  1955-01       Impact factor: 14.808

6.  [Studies on transaminase (GOT, GPT). I. Changes of GOT, GPT activities in supernatant and mitochondrial fractions in the liver cell and electrophoretic patterns of serum GOT in rats with acute liver injury and patients with various liver disease].

Authors:  M Kawaguchi; Y Sano; S Takagi
Journal:  Nihon Naika Gakkai Zasshi       Date:  1966-01-10

7.  [On the behavior of mitochondrial and cytoplasmatic glutamic-oxalacetic transaminase (GOT) of the serum in various stages of viral hepatitis].

Authors:  L Villa; N Dioguardi; A Agostoni
Journal:  Klin Wochenschr       Date:  1967-01-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.